Last reviewed · How we verify

Preservative-Free Timolol maleate

Merck Sharp & Dohme LLC · Phase 3 active Small molecule

Preservative-Free Timolol maleate is a Non-selective beta-adrenergic antagonist Small molecule drug developed by Merck Sharp & Dohme LLC. It is currently in Phase 3 development for Open-angle glaucoma, Ocular hypertension. Also known as: Preservative-Free Timoptic.

Timolol maleate is a non-selective beta-adrenergic receptor antagonist that reduces intraocular pressure by decreasing aqueous humor production in the eye.

Timolol maleate is a non-selective beta-adrenergic receptor antagonist that reduces intraocular pressure by decreasing aqueous humor production in the eye. Used for Open-angle glaucoma, Ocular hypertension.

At a glance

Generic namePreservative-Free Timolol maleate
Also known asPreservative-Free Timoptic
SponsorMerck Sharp & Dohme LLC
Drug classNon-selective beta-adrenergic antagonist
TargetBeta-1 and beta-2 adrenergic receptors
ModalitySmall molecule
Therapeutic areaOphthalmology
PhasePhase 3

Mechanism of action

Timolol blocks beta-1 and beta-2 adrenergic receptors in the ciliary body of the eye, which reduces the rate of aqueous humor formation. This leads to a decrease in intraocular pressure, making it effective for treating glaucoma and ocular hypertension. The preservative-free formulation minimizes ocular surface irritation and is suitable for patients with sensitive eyes or those using multiple topical medications.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Preservative-Free Timolol maleate

What is Preservative-Free Timolol maleate?

Preservative-Free Timolol maleate is a Non-selective beta-adrenergic antagonist drug developed by Merck Sharp & Dohme LLC, indicated for Open-angle glaucoma, Ocular hypertension.

How does Preservative-Free Timolol maleate work?

Timolol maleate is a non-selective beta-adrenergic receptor antagonist that reduces intraocular pressure by decreasing aqueous humor production in the eye.

What is Preservative-Free Timolol maleate used for?

Preservative-Free Timolol maleate is indicated for Open-angle glaucoma, Ocular hypertension.

Who makes Preservative-Free Timolol maleate?

Preservative-Free Timolol maleate is developed by Merck Sharp & Dohme LLC (see full Merck Sharp & Dohme LLC pipeline at /company/merck).

Is Preservative-Free Timolol maleate also known as anything else?

Preservative-Free Timolol maleate is also known as Preservative-Free Timoptic.

What drug class is Preservative-Free Timolol maleate in?

Preservative-Free Timolol maleate belongs to the Non-selective beta-adrenergic antagonist class. See all Non-selective beta-adrenergic antagonist drugs at /class/non-selective-beta-adrenergic-antagonist.

What development phase is Preservative-Free Timolol maleate in?

Preservative-Free Timolol maleate is in Phase 3.

What are the side effects of Preservative-Free Timolol maleate?

Common side effects of Preservative-Free Timolol maleate include Ocular irritation or discomfort, Blurred vision, Conjunctival hyperemia, Systemic beta-blocker effects (bradycardia, bronchospasm in susceptible patients).

What does Preservative-Free Timolol maleate target?

Preservative-Free Timolol maleate targets Beta-1 and beta-2 adrenergic receptors and is a Non-selective beta-adrenergic antagonist.

Related